Table 2. Performance of QFT-G and TST in subgroups of HIV-TB patients.
Groups | QFT-G | TST | |||
% Pos (95%CI)) | % Neg (95%CI) | % Indt (95%CI) | % Pos (95%CI) | % Neg (95%CI)) | |
Overall (N = 105) | 65 (56–74) | 18 (11–25) | 17 (10–24) | 31 (22–40) | 69 (60–78) |
PTB (N = 66) | 59 (47–71) | 20 (10–30) | 21 (11–31) | 26 (15–37) | 74 (63–85) |
Sputum culture positive (N = 44) | 66 (52–80) | 11 (2–20) | 23 (11–35) | 25 (12–38) | 75 (62–88) |
Sputum culture negative (N = 22) | 45 (24–66) | 37 (17–57) | 8 (2–34) | 27 (8–46) | 73 (54–92) |
Sputum smear positive (N = 43) | 68 (54–82) | 9 (1–18) | 23 (10–36) | 26 (13–39) | 74 (61–87) |
Sputum Smear negative (N = 23) | 44 (24–64) | 39 (19–59) | 17 (2–32) | 26 (8–44) | 74 (56–92) |
EPTB (N = 39) | 77 (64–90) | 13 (2–24) | 10 (1–19) | 41 (25–56) | 59 (44–74) |
Pos – Positive.
Neg – Negative.
Indt – Indeterminate.
Sen - Sensitivity.
PTB – Pulmonary tuberculosis.
EPTB- Extra-pulmonary tuberculosis.